Marco Y. W. Zaki - Concepedia

Author

Marco Y. W. Zaki

Also Known As

M Zaki, M. Y. Zaki, M. Zaki, M.Y.W. Zaki, Marco Y W Zaki, Marco Y. W. Zaki, Marco Y.W. Zaki, Marco Youssef William Zaki, Marco Zaki

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Newcastle University Minia University Newcastle upon Tyne Hospitals NHS Foundation Trust National and Kapodistrian University of Athens Freeman Hospital

About

Marco Y. W. Zaki is an author at Newcastle University specializing in medicine, metabolic syndrome, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	332
2	Public Health	2	2	96
3	Health Sciences	1	1	178
4	Natural Sciences	1	1	20
5	Biochemistry	1	1	20

Marco Y. W. Zaki

Publications

973

Citations

H-Index

Page 1

	Year	Citations
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? Ramy Younes, Olivier Govaere, Salvatore Petta, Gut	2021	191
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease Ramy Younes, Gian Paolo Caviglia, Olivier Govaere, Journal of Hepatology ObesityMetabolic SyndromeHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver Disease	2021	178
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms Aitor Esparza-Baquer, Ibone Labiano, Omar Sharif, Gut	2020	112
A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision‐Cut Liver Slices Hannah L. Paish, Lee H. Reed, Helen Brown, Hepatology	2019	105
Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus Olusegun A. Mojiminiyi, Nabila Abdella, Mahmoud Moussa, Diabetes Research and Clinical Practice InflammationMetabolic SyndromeC-reactive ProteinCardiovascular DiseaseAtherosclerosis	2002	60
Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance Nabila Abdella, Olusegun A. Mojiminiyi, Mahmoud Moussa, Diabetic Medicine	2005	46
Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate Cells Eva Morán‐Salvador, Marina García‐Macía, Ashwin Sivaharan, Gastroenterology	2019	40
c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis Jack Leslie, Marina García‐Macía, Saimir Luli, Nature Metabolism FibrosisCell RegulationC-rel OrchestratesCell SignalingMatrix Biology	2020	38
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease Angelo Armandi, Tiziana Sanavia, Ramy Younes, Gut Metabolic DisorderLiver-related EventsPrognosisPathologySerum Ferritin Levels	2024	36
Prevalence and associations of low plasma erythropoietin in patients with Type 2 diabetes mellitus Olusegun A. Mojiminiyi, Nabila Abdella, Marco Y. W. Zaki, Diabetic Medicine	2006	34

Page 1